The global flow cytometry market was valued at USD 4.65 billion in 2023, growing at a CAGR of 8.13% from 2024 to 2033. The market is expected to reach USD 10.16 billion by 2033. The growing prevalence of immunodeficiency disorders, cancer, and infectious diseases is expected to drive the market's growth. Moreover, rising R&D investments in life science, biotechnology, and biopharmaceutical research activities also add impetus to the market's growth. As a result of the COVID-19 pandemic, there has been an increase in the use of flow cytometry.
